APOE and Alzheimer disease: The ASIC-E4 study aims to investigate the early interplay of Aβ deposition, neuroinflammation and synaptic loss in cognitively unimpaired elderly with varying levels of genetic risk for AD, based on their APOE ε4 gene dose.